Inhibitory signals are generated upon PD-1/PD-L1 binding, which suppress the anti-tumor immune responses by inducing T cell apoptosis, and inhibiting cytotoxic T cell activation and cytokine production [12]. This evidence concerns the gene PDCD1 and neoplasm.